70 phenotypes from 6 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Wasltm1.1Cgn/Wasltm1.1Cgn C57BL/6-Wasltm1.1Cgn	abnormal allantois morphology	J:73609
	abnormal ectoplacental cavity morphology	J:73609
	abnormal extraembryonic mesoderm development	J:73609
	abnormal gastrulation	J:73609
	abnormal mesoderm development	J:73609
	decreased embryo size	J:73609
	failure of initiation of embryo turning	J:73609
	prenatal lethality, complete penetrance	J:73609
Wasltm1.1Sbs/Wasltm1.1Sbs either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6)	prenatal lethality, complete penetrance	J:72053
Wasltm1.1Ttha/Wasl+ Tg(Nes-cre)1Kag/0 involves: C57BL/6 * SJL	no abnormal phenotype detected	J:207484
Wasltm1.1Ttha/Wasltm1.1Ttha Tg(KRT14-cre)1Amc/0 involves: C57BL/6 * C57BL/6N * CBA	abnormal circulating chemokine level	J:271857
	abnormal esophagus morphology	J:271857
	abnormal skin appearance	J:271857
	alopecia	J:271857
	decreased body weight	J:271857
	dermatitis	J:271857
	dilated esophagus	J:271857
	dry skin	J:271857
	epidermal hyperplasia	J:271857
	impaired skin barrier function	J:271857
	increased circulating interleukin-1 alpha level	J:271857
	increased circulating interleukin-6 level	J:271857
	increased circulating interleukin-17 level	J:271857
	increased circulating tumor necrosis factor level	J:271857
	increased keratinocyte proliferation	J:271857
	increased susceptibility to bacterial infection	J:271857
	postnatal growth retardation	J:271857
	premature death	J:271857
	scaly skin	J:271857
	skin inflammation	J:271857
	thick epidermis	J:271857
	wrinkled skin	J:271857
Wasltm1.1Ttha/Wasltm1.1Ttha Tg(Nes-cre)1Kag/0 involves: C57BL/6 * SJL	abnormal brain ependyma morphology	J:207484
	abnormal brain vasculature morphology	J:207484
	abnormal cerebral aqueduct morphology	J:207484
	abnormal cerebral cortex morphology	J:207484
	abnormal choroid plexus morphology	J:207484
	abnormal dorsal striatum morphology	J:207484
	abnormal gait	J:207484
	abnormal postnatal subventricular zone morphology	J:207484
	abnormal septum of telencephalon morphology	J:207484
	abnormal spine curvature	J:207484
	absent brain ependyma motile cilia	J:207484
	absent hippocampus	J:207484
	astrocytosis	J:207484
	cerebral aqueductal stenosis	J:207484
	decreased body size	J:207484
	decreased body weight	J:207484
	decreased corpus callosum size	J:207484
	dilated fourth ventricle	J:207484
	dilated lateral ventricle	J:207484
	domed cranium	J:207484
	enlarged brain ventricles	J:207484
	enlarged cranium	J:207484
	hydrocephaly	J:207484
	increased brain size	J:207484
	kyphosis	J:207484
	lethargy	J:207484
	obstructive hydrocephaly	J:207484
	postnatal growth retardation	J:207484
	postnatal lethality, complete penetrance	J:207484
	thin cerebral cortex	J:207484
Wasltm1Cgn/Wasltm1Cgn C57BL/6-Wasltm1Cgn	no abnormal phenotype detected	J:73609
Wasltm1Sbs/Wasltm1Sbs either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6)	abnormal cell chemotaxis	J:72053
	absent heartbeat	J:72053
	decreased embryo size	J:72053
	decreased fibroblast proliferation	J:72053
	delayed embryo turning	J:72053
	dilated heart	J:72053
	embryonic growth retardation	J:72053
	embryonic lethality during organogenesis, complete penetrance	J:72053
	wavy neural tube	J:72053
Wasltm2Sbs/Wasltm2Sbs Six2tm1(tTA,tetO-EGFP/cre)Amc/Six2+ involves: 129 * C57BL/6J	decreased renal glomerulus number	J:195266
	decreased renal tubule number	J:195266
	renal hypoplasia	J:195266